300 related articles for article (PubMed ID: 36243653)
1. Implementing comprehensive pharmacogenomics in a community hospital-associated primary care setting.
Wick JA; Schmidlen T; Grande K; Moretz C; Ashcraft K; Green J; Moyer N; Blaxall BC
J Am Pharm Assoc (2003); 2023; 63(1):188-192. PubMed ID: 36243653
[TBL] [Abstract][Full Text] [Related]
2. Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients.
Kim K; Magness JW; Nelson R; Baron V; Brixner DI
J Manag Care Spec Pharm; 2018 Dec; 24(12):1250-1259. PubMed ID: 30479202
[TBL] [Abstract][Full Text] [Related]
3. Prescription medications with actionable pharmacogenomic recommendations in Veterans Health Administration patients.
Maghari S; Gallo T; Rivas S; German A; Nguyen Le MQ; Abbaszadegan H; Zubriski MA; Heise CW; Landas ND
Pharmacogenomics; 2023 Jun; 24(9):501-508. PubMed ID: 37435738
[No Abstract] [Full Text] [Related]
4. Pharmacogenomics of medications given via nonconventional administration routes: a scoping review.
Socco S; Wake DT; Lee JC; Dunnenberger HM
Pharmacogenomics; 2022 Nov; 23(17):933-948. PubMed ID: 36326000
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics: Prescribing Precisely.
Wake DT; Ilbawi N; Dunnenberger HM; Hulick PJ
Med Clin North Am; 2019 Nov; 103(6):977-990. PubMed ID: 31582008
[TBL] [Abstract][Full Text] [Related]
6. Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact.
van der Wouden CH; Bank PCD; Ă–zokcu K; Swen JJ; Guchelaar HJ
Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146504
[TBL] [Abstract][Full Text] [Related]
7. Evolution of pharmacogenomic services and implementation of a multi-state pharmacogenomics clinic across a large rural healthcare system.
Van Heukelom J; Morgan J; Massmann A; Jacobsen K; Petry NJ; Baye JF; Frear S; Schultz A
Front Pharmacol; 2023; 14():1274165. PubMed ID: 38035031
[No Abstract] [Full Text] [Related]
8. Nine-gene pharmacogenomics profile service: The Mayo Clinic experience.
Matey ET; Ragan AK; Oyen LJ; Vitek CR; Aoudia SL; Ragab AK; Fee-Schroeder KC; Black JL; Moyer AM; Nicholson WT; Shrestha S; McAllister TM; Sinnwell JP; Faubion SS; Lazaridis KN
Pharmacogenomics J; 2022 Feb; 22(1):69-74. PubMed ID: 34671112
[TBL] [Abstract][Full Text] [Related]
9. Implementation of a Standardized Medication Therapy Management Plus Approach within Primary Care.
Schwartz EJ; Turgeon J; Patel J; Patel P; Shah H; Issa AM; Knowlton OV; Knowlton CH; Bain KT
J Am Board Fam Med; 2017; 30(6):701-714. PubMed ID: 29180545
[TBL] [Abstract][Full Text] [Related]
10. Integration of a pharmacist-led pharmacogenomic service in a geriatric clinic: Barriers and outcomes.
Kehr AM; Ayers G; Saxena S; Hashmi AZ; Erwin AL; Azene A; Hockings JK
J Am Pharm Assoc (2003); 2023; 63(3):778-784. PubMed ID: 36774236
[TBL] [Abstract][Full Text] [Related]
11. An EMR-Based Approach to Determine Frequency, Prescribing Pattern, and Characteristics of Patients Receiving Drugs with Pharmacogenomic Guidelines.
MacKinnon GE; Mills M; Stoddard A; Urrutia RA; Broeckel U
Pharmacy (Basel); 2023 Nov; 11(6):. PubMed ID: 37987388
[TBL] [Abstract][Full Text] [Related]
12. Description of Pharmacogenomic Testing Among Patients Admitted to the Intensive Care Unit After Cardiovascular Surgery.
Peterson PE; Nicholson WT; Moyer AM; Arendt CJ; Smischney NJ; Seelhammer TG; Krecke CA; Haney RM; Yaw EJ; Chlan LL
J Intensive Care Med; 2021 Nov; 36(11):1281-1285. PubMed ID: 32734840
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care.
Bank PCD; Swen JJ; Schaap RD; Klootwijk DB; Baak-Pablo R; Guchelaar HJ
Eur J Hum Genet; 2019 Oct; 27(10):1532-1541. PubMed ID: 31227807
[TBL] [Abstract][Full Text] [Related]
14. The Innovative Canadian Pharmacogenomic Screening Initiative in Community Pharmacy (ICANPIC) study.
Papastergiou J; Tolios P; Li W; Li J
J Am Pharm Assoc (2003); 2017; 57(5):624-629. PubMed ID: 28689706
[TBL] [Abstract][Full Text] [Related]
15. Primary Care Prescription Drug Use and Related Actionable Drug-Gene Interactions in the Danish Population.
Lunenburg CATC; Hauser AS; Ishtiak-Ahmed K; Gasse C
Clin Transl Sci; 2020 Jul; 13(4):798-806. PubMed ID: 32166845
[TBL] [Abstract][Full Text] [Related]
16. Patient perceptions of pharmacogenomic testing in the community pharmacy setting.
Bright D; Worley M; Porter BL
Res Social Adm Pharm; 2021 Apr; 17(4):744-749. PubMed ID: 32741696
[TBL] [Abstract][Full Text] [Related]
17. Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing.
Reizine NM; Danahey K; Truong TM; George D; House LK; Karrison TG; van Wijk XMR; Yeo KJ; Ratain MJ; O'Donnell PH
Cancer; 2022 Apr; 128(8):1649-1657. PubMed ID: 35090043
[TBL] [Abstract][Full Text] [Related]
18. Effect of pharmacogenomic testing on pharmacotherapy decision making in patients with symptoms of depression in an interprofessional primary care clinic.
Roscizewski L; Henneman A; Snyder T
J Am Pharm Assoc (2003); 2022; 62(2):569-574.e1. PubMed ID: 34801407
[TBL] [Abstract][Full Text] [Related]
19. Applications for pharmacogenomics in pharmacy practice: A scoping review.
Hayashi M; Hamdy DA; Mahmoud SH
Res Social Adm Pharm; 2022 Jul; 18(7):3094-3118. PubMed ID: 34474980
[TBL] [Abstract][Full Text] [Related]
20. Asynchronous consult report generation for pharmacogenomic clinical support: Time and motion.
Bright DR; Klepser D; Langerveld A
Res Social Adm Pharm; 2024 Jun; 20(6):152-155. PubMed ID: 38494381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]